Regulatory

Regulatory  ·  Weekly Digest - 28 February to 06 March 2026
ENHERTU Supplemental New Drug Application submitted in Japan as adjuvant therapy for patients with HER2 positive early breast cancer

Weekly Digest – March 2026 Weekly Digest – March 2026 27 February 2026: ENHERTU Supplemental New Drug Application submitted in Japan as adjuvant therapy for patients with HER2 positive early breast cancer Daiichi Sankyo has taken a new step to […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 28 February to 06 March 2026
ABL Bio–NEOK Bio receive U.S. IND clearance for phase 1 clinical trial of ABL209 (NEOK002)

Weekly Digest – March 2026 Weekly Digest – March 2026 03 March 2026: ABL Bio–NEOK Bio receive U.S. IND clearance for phase 1 clinical trial of ABL209 (NEOK002) ABL Bio and NEOK Bio have advanced their next-generation ADC pipeline after […]

by Sandhya Ramalingam

Continue Reading